Intellia Therapeutics, Inc. short interest in 2024
In 2024, Intellia Therapeutics, Inc.'s disclosed short interest ran from 11.67% of shares outstanding on 12 Jan 2024 to 21.27% on 31 Dec 2024, a change of +9.60 percentage points. The year's high was 21.27% on 31 Dec 2024 and its low 11.67% on 12 Jan 2024, averaging 15.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.02 days on 30 Aug 2024. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 11.67% (12 Jan 2024)
- End of year
- 21.27% (31 Dec 2024)
- Change
- +9.60 pp
- High
- 21.27% (31 Dec 2024)
- Low
- 11.67% (12 Jan 2024)
- Average
- 15.30%
- Highest days to cover
- 14.02 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 11.67% | 7.69 | results (8-K) |
| 31 Jan 2024 | 12.25% | 7.64 | |
| 15 Feb 2024 | 12.98% | 6.94 | |
| 29 Feb 2024 | 14.09% | 5.40 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 15.08% | 8.77 | |
| 28 Mar 2024 | 16.56% | 13.84 | |
| 15 Apr 2024 | 16.29% | 11.57 | |
| 30 Apr 2024 | 17.24% | 13.52 | |
| 15 May 2024 | 15.72% | 10.44 | 10-Q filed, results (8-K) |
| 31 May 2024 | 15.23% | 9.80 | |
| 14 Jun 2024 | 14.24% | 7.24 | |
| 28 Jun 2024 | 13.74% | 5.85 | |
| 15 Jul 2024 | 14.35% | 9.13 | |
| 31 Jul 2024 | 13.86% | 9.07 | |
| 15 Aug 2024 | 13.61% | 10.24 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 13.49% | 14.02 | |
| 13 Sep 2024 | 14.53% | 10.78 | |
| 30 Sep 2024 | 14.91% | 9.87 | |
| 15 Oct 2024 | 16.11% | 8.75 | |
| 31 Oct 2024 | 15.90% | 4.86 | |
| 15 Nov 2024 | 16.07% | 6.47 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 18.57% | 5.83 | |
| 13 Dec 2024 | 19.45% | 9.36 | |
| 31 Dec 2024 | 21.27% | 8.78 |
See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.